Broncomar EXPECTORANT is a Oral Liquid in the Human Otc Drug category. It is labeled and distributed by Dannso Corp./d.b.a. Essential Products. The primary component is Acetaminophen; Dextromethorphan Hydrobromide; Guaifenesin; Phenylephrine Hydrochloride.
Product ID | 70242-102_3ea25d94-751b-4e7f-959c-657688687cdd |
NDC | 70242-102 |
Product Type | Human Otc Drug |
Proprietary Name | Broncomar EXPECTORANT |
Generic Name | Acetaminofen, Dextromethorphan Hbr, Guaifenesin, Phenylephrine Hcl |
Dosage Form | Liquid |
Route of Administration | ORAL |
Marketing Start Date | 2001-10-01 |
Marketing Category | OTC MONOGRAPH FINAL / OTC MONOGRAPH FINAL |
Application Number | part341 |
Labeler Name | Dannso Corp./d.b.a. Essential Products |
Substance Name | ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE |
Active Ingredient Strength | 250 mg/10mL; mg/10mL; mg/10mL; mg/10mL |
NDC Exclude Flag | N |
Listing Certified Through | 2021-12-31 |
Marketing Start Date | 2015-01-01 |
NDC Exclude Flag | N |
Sample Package? | N |
Marketing Category | OTC monograph final |
Application Number | part341 |
Product Type | HUMAN OTC DRUG |
Marketing Start Date | 2015-01-01 |
Inactivation Date | 2020-01-31 |
Ingredient | Strength |
---|---|
ACETAMINOPHEN | 250 mg/10mL |
SPL SET ID: | fef0c576-5fe2-42c5-9c4f-47dab6e940bb |
Manufacturer | |
UNII | |
RxNorm Concept Unique ID - RxCUI |
NDC | Brand Name | Generic Name |
---|---|---|
70242-100 | Broncomar Expectorant | Guaifenesin |
70242-102 | Broncomar | Acetaminofen, Dextromethorphan HBr, Guaifenesin, Phenylephrine HCl |
53149-2002 | Novalgina | Acetaminofen, Dextromethorphan HBr, Guaifenesin, Phenylephrine HCl |
83057-0001 | Novalgina | Acetaminofen, Dextromethorphan HBr, Guaifenesin, Phenylephrine HCl |
Mark Image Registration | Serial | Company Trademark Application Date |
---|---|
BRONCOMAR 86169790 4543652 Live/Registered |
J.J.J DISTRIBUTORS 2014-01-20 |
BRONCOMAR 73043470 1026059 Dead/Expired |
MARLOP PHARMACEUTICALS, INC. 1975-02-05 |